Lockheed Martin’s Missile Boom Meets an F-35 Funding Test

Third-quarter sales rose 11% to $20.7 billion and backlog reached a record $292 billion, yet flat margins and an underfunded F-35 lot show where the real test for investors now lies.

Key Takeaways

• EPS of $7.97 beat consensus near $7.52 as sales rose 11%, and backlog jumped 27% in three months to $292 billion, lifted by $52.5 billion from the PAC-3 MSE multiyear award.
• Guidance rose for a second straight quarter, but consolidated operating profit guidance fell $25 million at the midpoint, leaving the higher EPS outlook resting below the operating line.
• Lot 20 F-35 costs now exceed authorized funding and nine-month deliveries fell to 94 from 143, keeping the fighter program the clearest risk to cash flow and earnings quality.

Growth on Every Front

Lockheed Martin entered its third-quarter report carrying a burden of proof. A strong July had restored some confidence after last year’s program charges, but the shares still sat roughly a fifth below their March peak, and investors wanted evidence that the recovery had depth. On Thursday the company supplied it. Sales rose 11% to $20.7 billion from $18.6 billion, and all four business segments grew. Net earnings increased 14% to $1.85 billion, or $7.97 per diluted share, compared with $6.95 a year earlier and a consensus estimate of roughly $7.52.

The figure that will define the quarter, however, is backlog. Orders lifted it 27% in three months to a record $292.0 billion, against $193.6 billion at the end of 2025. At the midpoint of the new sales outlook, that represents roughly three and a half years of revenue, an unusual degree of visibility for a company of this size. Management raised guidance for sales, earnings per share and free cash flow for the second consecutive quarter, with Chief Executive Jim Taiclet pointing to “sustained financial momentum across our portfolio.” The more demanding question, and the one that will shape the stock from here, is how much of that order book becomes profit and cash, and on what terms.

The Munitions Engine

Missiles and Fire Control carried the quarter. Segment sales rose 24% to $4.5 billion and operating profit grew at the same rate to $631 million, leaving margin at 14.0%, essentially unchanged from 14.1% a year earlier. That stability matters more than the growth itself. Production ramps usually compress returns as new lines absorb labor, tooling and learning costs, yet this one has so far scaled without visible dilution. Integrated air and missile defense added $480 million of sales on higher PAC-3 and THAAD output, while tactical and strike programs, led by GMLRS and the Precision Strike Missile, contributed $330 million. The segment’s backlog now stands at $142.5 billion, roughly three times its year-end level and close to half the company total.

The source of that surge is a change in how Washington buys weapons. On July 29 the Army awarded Lockheed a seven-year undefinitized contract action worth up to $53.86 billion for PAC-3 MSE interceptors, lifting the multiyear ceiling to $58.62 billion, and the company intends to triple production capacity by the end of 2030. The award followed a $35 billion THAAD agreement signed in the second quarter. Together they mark a shift away from annual, stop-start procurement toward commitments long enough to justify new factories. The fine print deserves equal attention. The PAC-3 action is not yet definitized, the Army noted that no funds were obligated at signing, and the final price, which will set the program’s margin for seven years, is still to be negotiated. The backlog represents real demand. It does not yet represent settled economics.

What the Margins Reveal

Look past the growth and profitability is steady rather than improving. Business segment operating profit rose 10% to $2.23 billion, but segment margin slipped to 10.8% from 10.9%. Consolidated margin fell further, to 11.8% from 12.3%, as unallocated “other, net” costs widened to $158 million from $59 million. Aeronautics illustrates the pattern. Its sales rose 13% on $710 million of additional F-35 production and sustainment volume and $270 million from the C-130, the latter reflecting the liquidation of pre-contract costs tied to an anticipated award, a contribution unlikely to recur at that scale. Margin nonetheless fell to 9.0% from 9.4% after $40 million of unfavorable profit adjustments on each of the F-16 and C-130 programs. At Rotary and Mission Systems, a $40 million favorable contract resolution was absorbed by $45 million of unfavorable adjustments on the Heavy Lift and Seahawk helicopters.

Much of the remaining improvement came from below the operating line. The effective tax rate fell to 15.1% from 16.5%, helped by larger deductions for foreign-derived income. At last year’s rate, tax expense would have been about $31 million higher, worth roughly 14 cents a share, or 13% of the $1.02 increase in EPS. Interest expense also eased to $264 million from $286 million. The revised outlook carries the same signature. The sales midpoint rose $250 million, yet segment operating profit guidance gained only $25 million at the midpoint, and consolidated operating profit guidance declined by $25 million. The 25-cent increase in the EPS midpoint, to $30.55, therefore owes more to items below the operating line than to the business itself. None of this undermines the quarter, but it qualifies it: Lockheed is growing volume faster than it is growing margin.

The F-35 Problem Returns

The most consequential disclosure in the release occupied a single paragraph. Lockheed remains in negotiations with the government over production contracts for F-35 Lots 20 and beyond, and during the third quarter its costs on the Lot 20 advance acquisition contract began to exceed the authorization and funding in place. Without additional authorization and funding, the company warned, its results, cash flows and financial condition will be negatively affected in future periods. Investors have seen this before. The Lots 18 and 19 agreement arrived roughly a year late, obliging Lockheed to finance production from its own resources in the interim. Lot 20 was separated from the customary three-lot bundle because it could anchor a long-planned multiyear contract, which raises the stakes of a negotiation in which Lockheed is already spending ahead of its authorization.

The operating record sends mixed signals. Lockheed delivered 43 F-35s in the quarter, against 46 a year earlier, and 94 over nine months, against a record 143, even as F-35 revenue rose on production and sustainment volume. Aeronautics was also the only segment whose backlog contracted, to $57.3 billion from $59.4 billion at year-end, a reminder that the company’s order momentum is concentrated in missiles rather than aircraft. Space offered stability without acceleration. Sales rose 4% as the Fleet Ballistic Missile and Next Generation Interceptor programs added $185 million, partly offset by a $115 million decline on the OPIR missile-warning mission as it moved through its lifecycle, leaving operating profit flat at $331 million.

Capital, Policy and a Patient Market

Cash generation softened in the quarter but strengthened in the outlook. Operating cash flow was $3.4 billion and free cash flow $3.0 billion, down from $3.7 billion and $3.3 billion a year earlier, when customer receipts ran higher. Capital expenditure of $439 million and independent research and development of $599 million point to a company investing ahead of its order book. Full-year free cash flow guidance nonetheless rose to $7.8 to $8.0 billion, from $7.0 to $7.2 billion. How that cash is deployed is now shaped in Washington as much as in Bethesda. Executive Order 14372, signed in January, ties defense contractors’ buybacks and dividends to delivery performance and production investment. Lockheed repurchased no stock in the first nine months, against $2.25 billion a year earlier, while paying $2.41 billion in dividends, retiring $1.17 billion of debt and lifting its quarterly dividend to $3.60, a 24th consecutive annual increase.

The market’s response was restrained. The shares closed Wednesday at $551.51, about 20% below March’s record of $692, and options had priced a move of roughly 4.5% in either direction. Early trading pointed to a modest gain, well short of July, when a beat and raise lifted the stock by double digits. That restraint reflects patience more than doubt. Investors credited the backlog story three months ago. What they await now is conversion: definitizing PAC-3 on acceptable terms, securing Lot 20 funding and holding margins as volume climbs. Guidance implies fourth-quarter EPS of $7.99 to $8.39 in a 14-week quarter, and those results will offer the first clear read on whether the economics are keeping pace with demand. Lockheed has secured the orders. The task now is to prove they are worth what they appear to be.